Elucidation of Arvcf-dependent mechanisms required for lens function

阐明晶状体功能所需的 Arvcf 依赖性机制

基本信息

  • 批准号:
    10615869
  • 负责人:
  • 金额:
    $ 39.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-05-01 至 2026-03-31
  • 项目状态:
    未结题

项目摘要

Abstract: The function of the lens requires the maintenance of its transparency and refractive properties throughout its lifespan but those mechanisms responsible are not well understood. While important cellular functions and pathways such as cell adhesion or GTPase signaling have long been hypothesized to play a role in preserving these functions the removal of genes associated with these cellular functions often severely disrupt the lens making the contribution of them challenging to interpret. We have overcome this barrier with the discovery that mice lacking the Arvcf gene develop bilateral, age- dependent cortical cataracts. Arvcf is a member of the p120-catenin subfamily of catenins that bind to a specific intracellular domain of cadherins and regulate Rho-GTPases and junctional protein dynamics and stability. We have additionally found that Arvcf is highly enriched within lens fiber cell junctional structures and is required for the recruitment of several proteins to the cadherin complex, normal lens refraction, preservation of fiber cell morphology, organization of the F-actin architecture, and the normal biomechanical properties of the lens. We propose three aims to address the central question: What molecular functions lie downstream of Arvcf to maintain lens transparency, refraction, cell morphology, and biomechanical properties? In the first aim we will determine which of these properties, precede, follow, or are simultaneous with cadherin complex and adherens junction instability in Arvcf deficient lenses. We will test the hypothesis that the initiating event is the reduction of cadherin complex proteins in fiber cell membranes through a combination of biophysical property measurements of whole lenses and fluorescent/electron microscopy of lens fiber cells. Our early investigations also found that Aquaporin 0 (AQP0) depends on Arvcf to associate with the cadherin complex and novel quantitative analysis of super-resolution microscopy images of interlocking protrusions demonstrated a significant reduction of AQP0 from the distal tips of these structures. Therefore, in the second Aim of this proposal we plan to test the hypothesis that Arvcf recruits AQP0 to the tips of interlocking protrusions to facilitate cell adhesion and water transport by determining whether AQP0 and the Arvcf/N-cadherin protein complex function together in adhesion and water transport. In the third aim we will test the hypothesis that altered GTPase signaling downstream of Arvcf contributes to lens function. The GTPase regulation domain of Arvcf and candidate GTPase regulatory proteins will be genetically altered to determine their contribution to Arvcf function, lens fiber cell biology, and lens transparency. Together, these project aims will identify functional mechanisms of a previously untested and important protein required for lens transparency and lens fiber cell function. Furthermore, they will elucidate mechanisms underlying the etiology of age-dependent cortical cataracts. Because of the association of murine Arvcf with cortical cataracts and the human ARVCF gene with genetic disorders, neurological diseases, and cancer, the advances made on this proposal will also have a broad impact.
抽象的: 镜片的功能需要在其整个使用寿命期间保持其透明度和折射特性,但是 那些负责的机制还没有被很好地理解。虽然重要的细胞功能和途径,例如细胞 长期以来,人们一直假设粘附或 GTP 酶信号传导在保留这些功能(去除基因)方面发挥着作用 与这些细胞功能相关的通常会严重破坏晶状体,使得它们的贡献具有挑战性 解释。我们克服了这一障碍,发现缺乏 Arvcf 基因的小鼠发育出双侧、年龄- 依赖性皮质白内障。 Arvcf 是连环蛋白 p120-连环蛋白亚家族的成员,可与特定的细胞内结合 钙粘蛋白结构域并调节 Rho-GTP 酶和连接蛋白动力学和稳定性。我们还发现 Arvcf 在晶状体纤维细胞连接结构中高度富集,并且是招募多种蛋白质所必需的 钙粘蛋白复合物、正常晶状体屈光、纤维细胞形态的保存、F-肌动蛋白的组织 结构以及晶状体的正常生物力学特性。我们提出三个目标来解决核心问题: Arvcf 下游有哪些分子功能来维持晶状体透明度、折射、细胞形态和 生物力学特性?在第一个目标中,我们将确定这些属性中的哪些先于、后于或同时存在 Arvcf 缺陷晶状体中钙粘蛋白复合物和粘附连接不稳定。我们将检验以下假设: 起始事件是通过生物物理的组合减少纤维细胞膜中的钙粘蛋白复合物蛋白 整个晶状体的特性测量和晶状体纤维细胞的荧光/电子显微镜。我们的早期调查 还发现水通道蛋白 0 (AQP0) 依赖于 Arvcf 与钙粘蛋白复合物结合并进行新的定量 对互锁突起的超分辨率显微镜图像的分析表明 AQP0 显着降低 从这些结构的远端尖端。因此,在该提案的第二个目标中,我们计划检验以下假设: Arvcf 将 AQP0 招募到互锁突起的尖端,通过确定来促进细胞粘附和水运输 AQP0 和 Arvcf/N-钙粘蛋白复合物是否在粘附和水运输中共同发挥作用。在第三个 我们的目标是检验 Arvcf 下游 GTPase 信号传导的改变有助于晶状体功能的假设。 GTP酶 Arvcf 和候选 GTPase 调节蛋白的调节域将被基因改变以确定它们的 对 Arvcf 功能、晶状体纤维细胞生物学和晶状体透明度的贡献。这些项目目标共同确定 晶状体透明度和晶状体纤维细胞所需的先前未经测试的重要蛋白质的功能机制 功能。此外,他们还将阐明年龄依赖性皮质白内障病因的潜在机制。因为 小鼠 Arvcf 与皮质性白内障以及人类 ARVCF 基因与遗传性疾病、神经系统疾病之间的关系 疾病和癌症方面,这项提案取得的进展也将产生广泛的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Timothy F Plageman其他文献

Timothy F Plageman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Timothy F Plageman', 18)}}的其他基金

Characterization of the lens fiber cell tricellular junctional complex and its dependency on delta-catenin
晶状体纤维细胞三细胞连接复合体的表征及其对δ-连环蛋白的依赖性
  • 批准号:
    10738883
  • 财政年份:
    2023
  • 资助金额:
    $ 39.68万
  • 项目类别:
Characterizing the fundamental mechanisms of epithelial invagination during ocular morphogenesis
描述眼形态发生过程中上皮内陷的基本机制
  • 批准号:
    9978822
  • 财政年份:
    2016
  • 资助金额:
    $ 39.68万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.68万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.68万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.68万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.68万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.68万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.68万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.68万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.68万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.68万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.68万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了